Bringing the fundamentals into focus…
Back to Replimune Group, Inc.
How Replimune Group, Inc. stacks up
REPL · against 407 other Healthcare companies of similar size
Overall
18/ 100
Near the bottom of its peers.
Ranked #396 of 408 · scores higher than 3% of peers
Bars: peers in each 10-point band of the overall score9 peers with an overall score of 10–19, including REPL · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around REPL| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 2 | 15.6B DKK (≈$2.3B) | 96 | 96 | 99 | 96 | 0 / 2 | |
| 4 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 5 | 2.29T KRW (≈$1.6B) | 88 | 83 | 90 | 96 | 0 / 2 | |
| 390 | 232.9B JPY (≈$1.6B) | 20 | 0 | 6 | 4 | 0 / 2 | |
| 390 | 1.3B USD | 20 | 8 | 8 | 31 | 2 / 2 | |
| 390 | 2.4B USD | 20 | 8 | 8 | 7 | 1 / 2 | |
| 390 | 2.2B USD | 20 | 8 | 3 | 6 | 1 / 2 | |
| 396 | 1.9B USD | 18 | 8 | — | 8 | 1 / 2 | |
| 397 | 9.9B HKD (≈$1.3B) | 17 | 36 | 9 | 2 / 2 | ||
| 397 | 3.4B USD | 17 | 8 | — | 20 | 2 / 2 | |
| 399 | 1.0B EUR (≈$1.1B) | 16 | 0 | 37 | 17 | 2 / 2 | |
| 400 | 12.1B CNY (≈$1.7B) | 15 | 0 | 25 | 26 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score